Clinical Implementation Of Pharmacogenomics Testing To Guide P2y12 Inhibitor Use In Older Adults With Acute Coronary Syndrome: Insights From A Prospective Pilot Study
Circulation(2020)
Abstract
Introduction: CYP2C19 testing is a known pharmacogenomics application to identify patients who can activate clopidogrel. Evidence-based guidelines now support second generation P2Y12 inhibitors ove...
MoreTranslated text
Key words
guide p2y12 inhibitor use,pharmacogenomics testing,acute coronary syndrome,clinical implementation
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined